These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 20230542

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
    Tessari G, Naldi L, Boschiero L, Nacchia F, Fior F, Forni A, Rugiu C, Faggian G, Sassi F, Gotti E, Fiocchi R, Talamini G, Girolomoni G.
    Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
    Geusau A, Dunkler D, Messeritsch E, Sandor N, Heidler G, Rödler S, Ankersmit J, Zuckermann A, Tschachler E.
    Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M, Safranow K, Dziewanowski K, Debska-Slizień A, Głyda M, Gołembiewska E, Jankowska M, Nowosiad M, Rutkowski B, Ciechanowski K.
    Ann Acad Med Stetin; 2008 Sep; 54(1):41-8. PubMed ID: 19127808
    [Abstract] [Full Text] [Related]

  • 7. [Renal transplantation in patients with autosomal dominant polycystic kidney disease: pre-transplantation evaluation and follow-up].
    Bretagnol A, Büchler M, Boutin JM, Nivet H, Lebranchu Y, Chauveau D.
    Nephrol Ther; 2007 Dec; 3(7):449-55. PubMed ID: 18047999
    [Abstract] [Full Text] [Related]

  • 8. Autosomal-dominant polycystic kidney disease and kidney transplantation: experience of a single center.
    Gonçalves S, Guerra J, Santana A, Abreu F, Mil-Homens C, Gomes da Costa A.
    Transplant Proc; 2009 Apr; 41(3):887-90. PubMed ID: 19376380
    [Abstract] [Full Text] [Related]

  • 9. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.
    Mackenzie KA, Wells JE, Lynn KL, Simcock JW, Robinson BA, Roake JA, Currie MJ.
    Nephrol Dial Transplant; 2010 Jan; 25(1):300-6. PubMed ID: 19783601
    [Abstract] [Full Text] [Related]

  • 10. Favorable graft survival in renal transplant recipients with polycystic kidney disease.
    Johnston O, O'Kelly P, Donohue J, Walshe JJ, Little DM, Hickey D, Conlon PJ.
    Ren Fail; 2005 Jan; 27(3):309-14. PubMed ID: 15957548
    [Abstract] [Full Text] [Related]

  • 11. Skin surveillance of a U.K. paediatric transplant population.
    Thomson MA, Suggett NR, Nightingale PG, Milford DV, Baumann U, Kelly DA, Moss C, Hill VA.
    Br J Dermatol; 2007 Jan; 156(1):45-50. PubMed ID: 17199565
    [Abstract] [Full Text] [Related]

  • 12. New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: a retrospective cohort study.
    Ruderman I, Masterson R, Yates C, Gorelik A, Cohney SJ, Walker RG.
    Nephrology (Carlton); 2012 Jan; 17(1):89-96. PubMed ID: 21854501
    [Abstract] [Full Text] [Related]

  • 13. Nonmelanoma skin cancer after liver transplantation. Study of risk factors.
    Herrero JI, España A, Quiroga J, Sangro B, Pardo F, Alvárez-Cienfuegos J, Prieto J.
    Liver Transpl; 2005 Sep; 11(9):1100-6. PubMed ID: 16123952
    [Abstract] [Full Text] [Related]

  • 14. HLA-B27 is a potential risk factor for posttransplantation diabetes mellitus in autosomal dominant polycystic kidney disease patients.
    Pietrzak-Nowacka M, Safranow K, Nowosiad M, Dębska-Ślizień A, Dziewanowski K, Głyda M, Jankowska M, Rutkowski B, Ciechanowski K.
    Transplant Proc; 2010 Nov; 42(9):3465-70. PubMed ID: 21094798
    [Abstract] [Full Text] [Related]

  • 15. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia.
    Carroll RP, Ramsay HM, Fryer AA, Hawley CM, Nicol DL, Harden PN.
    Am J Kidney Dis; 2003 Mar; 41(3):676-83. PubMed ID: 12612993
    [Abstract] [Full Text] [Related]

  • 16. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ, Comber H, O'Lorcain P, O'Kelly P, Conlon PJ, Murphy GM.
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region.
    Bernat García J, Morales Suárez-Varela M, Vilata JJ, Marquina A, Pallardó L, Crespo J.
    Acta Derm Venereol; 2013 Jul 06; 93(4):422-7. PubMed ID: 23303600
    [Abstract] [Full Text] [Related]

  • 18. Excess risk of cancer in renal transplant patients.
    Kessler M, Jay N, Molle R, Guillemin F.
    Transpl Int; 2006 Nov 06; 19(11):908-14. PubMed ID: 17018126
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.